Clínica Universidad de Navarra/CIMA

FACTS AND HOPES IN
CANCER IMMUNOTHERAPY

Madrid. Nov. 22nd and 23rd, 2019

EVENT WILL START IN
  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Add to My Calendar 2019-11-22 14:30:00 2019-11-23 19:30:00 Europe/Madrid CANCER IMMUNOTHERAPY DAY Gather is a responsive event theme with many awesome features including add to my calendar feature. Awesome. huh? Madrid, España Clínica Universidad de Navarra / CIMA cancimmunoday@unav.es

FULL PROGRAM

DOWNLOAD PROGRAM

Opening

  • Esperanza Lozano, Director CUN. Madrid.
  • Ignacio Melero, CUN-CIMA. Pamplona.
14.20-14.30

KEYNOTE LECTURE

 

Chairs:

  • Miguel López-Botet, Universidad Pompeu Fabra. Barcelona.
  • Francisco Sánchez-Madrid, CNIC-Hospital de La Princesa. Madrid.

 

  • “NK cell-based Tumor Therapies”.
    Lorenzo Moretta. Ospedale Pediatrico Bambino Gesù. Rome.

 

  • Questions and answers
14.30-15.05

Session 1. CROSSPRIMING AND CANCER

Chairs:

  • David Sancho, CNIO. Madrid.
  • Alvaro Teijeira, CIMA. Pamplona.

 

  • “Crosspriming”.
    Sebastian Amigorena, Institut Curie. Paris.
  • “Inflammation and cancer immunogenicity”.
    Santiago Zelenay, The University of Manchester. UK.
  • “cDC1 and hot tumors”.
    Jason Luke, University of Pittsburgh Medical Center and Hillman Cancer Center. Pittsburgh.

 

  • Questions and answers
15.15-17.15

Break

17.15-18.00

Session 2. RADIOIMMUNOTHERAPY

Sponsored by EMD

Chairs:

  • Felipe Calvo, CUN. Madrid.
  • Rafael Martínez Monge, CUN. Pamplona.

 

  • “Obligometastasis and radiotherapy”.
    Ralph R. Weichselbaum, University of Chicago Medicine. Chicago.
  • “Radiotherapy and virotherapy”.
    Kevin Harrington, The Institute of Cancer Research. London.
  • “Abscopal effects of radioimmunotherapy”.
    María Rodríguez Ruiz, CUN. Pamplona

 

  • Questions and answers
18.00-20.00

Session 3. FACTS AND HOPES REACHING THE CLINIC (I)

Chairs:

  • Cristina Mingari, University of Genova. Ospedale Policlinico San Martino – IRCCS. Genova.
  • Miguel Fernández de Sanmamed, CUN. Pamplona.

 

  • “Immunotherapy of primary liver cancer”.
    Bruno Sangro, CUN. Pamplona.
  • “Immunotehrapy of esophageal and gastric cancer”.
    María Alsina, Vall d’Hebron Institute of Oncology (VHIO), Barcelona.
  • “New targets in immunotherapy: LAG3-FGL1 and SIGLEC 152”.
    Jun Wang, NY University. New York.

 

  • Questions and answers
8.30-10.30

Break

10.30-11.00

KEYNOTE LECTURE

Chairs:

  • Pedro Berraondo, CIMA. Pamplona.
  • Noelia Casares, CIMA. Pamplona.

 

  • “Creative biotechnology for cancer immunotherapy”
    Pablo Umaña, Roche Innovation Center. Zurich.
  • Questions and answers
11.00-11.45

Session 4. ADOPTIVE T-CELL THERAPY

Sponsored by GILEAD

Chairs:

  • Juan J. Lasarte, CIMA. Pamplona.
  • Paloma Sánchez-Mateos, Universidad Complutense de Madrid. Madrid.

 

  • “An introduction to adoptive T-Cell therapy”.
    Sandra Hervás. CIMA. Pamplona
  • “TIL Therapy”.
    Inge Marie Svane, University of Copenhagen. Dinamarca.
  • “CAR T-Cell Therapy”.
    Marcela Maus, MGH Center for Cancer Research. Charlestown, Massachusetts.

 

  • Questions and answers
11.45-13.45

Lunch Break

13.45-15.30

Session 5. FACTS AND HOPES REACHING THE CLINIC (II)

Chairs:

  • Ignacio Melero, CUN-CIMA. Pamplona.
  • Eduardo Castañón, CUN. Madrid.

 

  • “Immunotherapy of urogenital cancer”.
    José Luis Pérez Gracia, CUN. Pamplona
  • “Immunotherapy of ovarian cancer”.
    Antonio González, CUN. Madrid
  • “Immunotherapy of melanoma”.
    José María Piulats, Bellvitge Biomedical Research Institute. Barcelona

 

  • Questions and answers
15.30-17.30

ROUND TABLE “EARLY PHASE CLINICAL TRIALS IN CANCER IMMUNOTHERAPY”

Chairs:

  • Ignacio Melero, CUN-CIMA. Pamplona.
  • Eduardo Castañón, CUN. Madrid.

Panelists:

  • Emiliano Calvo, Centro Integral Oncológico Clara Campal. Madrid.
  • Elena Garralda, Vall d’Hebron Institute of Oncology (VHIO). Barcelona.
  • María Rodríguez Ruiz, CUN. Pamplona.
  • Iván Márquez Rodas, Hospital General Universitario Gregorio Marañón. Madrid.

 

  • Questions and answers
17.30-18.15

FAREWELL AND MEETING ADJOURNS

 

  • Ignacio Melero, CUN-CIMA. Pamplona.
  • Eduardo Castañón, CUN. Madrid.
  • Maria Rodriguez, CUN. Pamplona
  • Miguel Fernández de Sanmamed, CUN. Pamplona
  • Pedro Berraondo, CIMA. Pamplona
18.30

EVENT SUPPORTED BY

PLATINUM

Bristol-Myers-Squibb
Kite-Gilead-Company

GOLD

roche
msd
merck-cancerimmunotherapyday-cun

SILVER

Astrazeneca-CancerInmunotherapyDay
Alligator-Bioscience

BRONZE

bioncotech
bavarian
macs
Ciberonc

email-icon

CONTACT

Clínica Universidad de Navarra / CIMA
Cibeles Pinto

cancimmunoday@unav.es

+34 948194700 x 4012

Fundacion Areces

ADDRESS

Fundación Ramón Areces.

Calle Vitruvio, 5,
28006 Madrid, Spain.

Time: 9:30 AM to 19:00 PM. Monday to friday.

SEND US A MESSAGE

If you have any questions about the event, please contact us directly. We will respond for sure.






back to top